nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP2B6—Raloxifene—osteoporosis	0.116	0.144	CbGbCtD
Nitric Oxide—CYP2B6—Ethinyl Estradiol—osteoporosis	0.112	0.139	CbGbCtD
Nitric Oxide—CYP1A2—Estropipate—osteoporosis	0.102	0.127	CbGbCtD
Nitric Oxide—CYP2B6—Cholecalciferol—osteoporosis	0.0897	0.111	CbGbCtD
Nitric Oxide—CYP3A4—Estropipate—osteoporosis	0.0535	0.0664	CbGbCtD
Nitric Oxide—CYP3A4—Calcitriol—osteoporosis	0.0535	0.0664	CbGbCtD
Nitric Oxide—CYP1A2—Conjugated Estrogens—osteoporosis	0.0483	0.0599	CbGbCtD
Nitric Oxide—CYP3A4—Ergocalciferol—osteoporosis	0.0428	0.0531	CbGbCtD
Nitric Oxide—CYP1A2—Estradiol—osteoporosis	0.0424	0.0526	CbGbCtD
Nitric Oxide—CYP3A4—Raloxifene—osteoporosis	0.0357	0.0443	CbGbCtD
Nitric Oxide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0345	0.0428	CbGbCtD
Nitric Oxide—CYP3A4—Cholecalciferol—osteoporosis	0.0276	0.0342	CbGbCtD
Nitric Oxide—CYP3A4—Conjugated Estrogens—osteoporosis	0.0253	0.0314	CbGbCtD
Nitric Oxide—CYP3A4—Estradiol—osteoporosis	0.0222	0.0276	CbGbCtD
Nitric Oxide—Cerebral infarction—Ethinyl Estradiol—osteoporosis	0.00937	0.0633	CcSEcCtD
Nitric Oxide—Methaemoglobinaemia—Conjugated Estrogens—osteoporosis	0.00847	0.0572	CcSEcCtD
Nitric Oxide—Dry throat—Estradiol—osteoporosis	0.00486	0.0328	CcSEcCtD
Nitric Oxide—Bradycardia—Calcium Acetate—osteoporosis	0.00339	0.0229	CcSEcCtD
Nitric Oxide—Shock—Calcium Acetate—osteoporosis	0.00233	0.0157	CcSEcCtD
Nitric Oxide—Chest discomfort—Estradiol—osteoporosis	0.00225	0.0152	CcSEcCtD
Nitric Oxide—Hypotension—Calcium Acetate—osteoporosis	0.00221	0.0149	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.00205	0.0139	CcSEcCtD
Nitric Oxide—Haemoglobin—Alendronate—osteoporosis	0.00187	0.0127	CcSEcCtD
Nitric Oxide—Haemorrhage—Alendronate—osteoporosis	0.00186	0.0126	CcSEcCtD
Nitric Oxide—Haemoglobin—Ibandronate—osteoporosis	0.00182	0.0123	CcSEcCtD
Nitric Oxide—Haemorrhage—Ibandronate—osteoporosis	0.00181	0.0123	CcSEcCtD
Nitric Oxide—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0018	0.039	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Calcitriol—osteoporosis	0.00178	0.0121	CcSEcCtD
Nitric Oxide—Haemorrhage—Calcitriol—osteoporosis	0.00178	0.012	CcSEcCtD
Nitric Oxide—Cardiac disorder—Estropipate—osteoporosis	0.00176	0.0119	CcSEcCtD
Nitric Oxide—Angiopathy—Estropipate—osteoporosis	0.00172	0.0116	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Estropipate—osteoporosis	0.0017	0.0115	CcSEcCtD
Nitric Oxide—Cardiac disorder—Raloxifene—osteoporosis	0.0017	0.0115	CcSEcCtD
Nitric Oxide—Cardiac disorder—Ibandronate—osteoporosis	0.00168	0.0114	CcSEcCtD
Nitric Oxide—Angiopathy—Raloxifene—osteoporosis	0.00166	0.0112	CcSEcCtD
Nitric Oxide—Angiopathy—Ibandronate—osteoporosis	0.00165	0.0111	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Ibandronate—osteoporosis	0.00163	0.011	CcSEcCtD
Nitric Oxide—Dizziness—Calcium Acetate—osteoporosis	0.00156	0.0106	CcSEcCtD
Nitric Oxide—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00154	0.0104	CcSEcCtD
Nitric Oxide—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00153	0.0104	CcSEcCtD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00153	0.0332	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Risedronate—osteoporosis	0.0015	0.0102	CcSEcCtD
Nitric Oxide—Haemorrhage—Risedronate—osteoporosis	0.0015	0.0101	CcSEcCtD
Nitric Oxide—Haemoglobin—Pamidronate—osteoporosis	0.00143	0.00965	CcSEcCtD
Nitric Oxide—Haemorrhage—Pamidronate—osteoporosis	0.00142	0.0096	CcSEcCtD
Nitric Oxide—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00139	0.0094	CcSEcCtD
Nitric Oxide—Cardiac disorder—Risedronate—osteoporosis	0.00139	0.00938	CcSEcCtD
Nitric Oxide—Chest pain—Alendronate—osteoporosis	0.00138	0.00933	CcSEcCtD
Nitric Oxide—Chest pain—Raloxifene—osteoporosis	0.00136	0.00918	CcSEcCtD
Nitric Oxide—Angiopathy—Risedronate—osteoporosis	0.00136	0.00917	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Risedronate—osteoporosis	0.00135	0.00911	CcSEcCtD
Nitric Oxide—Chest pain—Ibandronate—osteoporosis	0.00134	0.00909	CcSEcCtD
Nitric Oxide—Convulsion—Calcitriol—osteoporosis	0.00134	0.00905	CcSEcCtD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ACTG1—osteoporosis	0.00134	0.029	CbGpPWpGaD
Nitric Oxide—Bradycardia—Zoledronate—osteoporosis	0.00132	0.00893	CcSEcCtD
Nitric Oxide—Cardiac disorder—Pamidronate—osteoporosis	0.00132	0.00891	CcSEcCtD
Nitric Oxide—Nervous system disorder—Estropipate—osteoporosis	0.00132	0.00891	CcSEcCtD
Nitric Oxide—Chest pain—Calcitriol—osteoporosis	0.00132	0.00889	CcSEcCtD
Nitric Oxide—Angiopathy—Pamidronate—osteoporosis	0.00129	0.00871	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Pamidronate—osteoporosis	0.00128	0.00866	CcSEcCtD
Nitric Oxide—Shock—Raloxifene—osteoporosis	0.00128	0.00866	CcSEcCtD
Nitric Oxide—Nervous system disorder—Raloxifene—osteoporosis	0.00128	0.00863	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Raloxifene—osteoporosis	0.00127	0.00861	CcSEcCtD
Nitric Oxide—Shock—Ibandronate—osteoporosis	0.00127	0.00857	CcSEcCtD
Nitric Oxide—Nervous system disorder—Ibandronate—osteoporosis	0.00126	0.00854	CcSEcCtD
Nitric Oxide—ALDH2—Tryptophan metabolism—CYP19A1—osteoporosis	0.00123	0.0266	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Zoledronate—osteoporosis	0.0012	0.00814	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—WDR1—osteoporosis	0.00119	0.0258	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—WDR1—osteoporosis	0.00119	0.0258	CbGpPWpGaD
Nitric Oxide—Angiopathy—Zoledronate—osteoporosis	0.00118	0.00796	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Zoledronate—osteoporosis	0.00117	0.00791	CcSEcCtD
Nitric Oxide—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00116	0.00784	CcSEcCtD
Nitric Oxide—Angiopathy—Conjugated Estrogens—osteoporosis	0.00113	0.00766	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00113	0.00761	CcSEcCtD
Nitric Oxide—Chest pain—Risedronate—osteoporosis	0.00111	0.00749	CcSEcCtD
Nitric Oxide—Convulsion—Pamidronate—osteoporosis	0.00107	0.00724	CcSEcCtD
Nitric Oxide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00107	0.00722	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—WDR1—osteoporosis	0.00106	0.023	CbGpPWpGaD
Nitric Oxide—Shock—Risedronate—osteoporosis	0.00104	0.00706	CcSEcCtD
Nitric Oxide—Nervous system disorder—Risedronate—osteoporosis	0.00104	0.00704	CcSEcCtD
Nitric Oxide—Haemoglobin—Estradiol—osteoporosis	0.00101	0.00679	CcSEcCtD
Nitric Oxide—Haemorrhage—Estradiol—osteoporosis	0.001	0.00676	CcSEcCtD
Nitric Oxide—Shock—Pamidronate—osteoporosis	0.000993	0.00671	CcSEcCtD
Nitric Oxide—Nervous system disorder—Pamidronate—osteoporosis	0.00099	0.00669	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Pamidronate—osteoporosis	0.000989	0.00668	CcSEcCtD
Nitric Oxide—Convulsion—Zoledronate—osteoporosis	0.000979	0.00662	CcSEcCtD
Nitric Oxide—Headache—Etidronic acid—osteoporosis	0.000973	0.00658	CcSEcCtD
Nitric Oxide—Chest pain—Zoledronate—osteoporosis	0.000962	0.0065	CcSEcCtD
Nitric Oxide—Dyspnoea—Risedronate—osteoporosis	0.000947	0.0064	CcSEcCtD
Nitric Oxide—Hypotension—Pamidronate—osteoporosis	0.000943	0.00638	CcSEcCtD
Nitric Oxide—Convulsion—Conjugated Estrogens—osteoporosis	0.000943	0.00637	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—CAP1—osteoporosis	0.000942	0.0204	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—CAP1—osteoporosis	0.000942	0.0204	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Estradiol—osteoporosis	0.000928	0.00627	CcSEcCtD
Nitric Oxide—Chest pain—Conjugated Estrogens—osteoporosis	0.000926	0.00626	CcSEcCtD
Nitric Oxide—Angiopathy—Estradiol—osteoporosis	0.000908	0.00613	CcSEcCtD
Nitric Oxide—Shock—Zoledronate—osteoporosis	0.000907	0.00613	CcSEcCtD
Nitric Oxide—Nervous system disorder—Zoledronate—osteoporosis	0.000904	0.00611	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Zoledronate—osteoporosis	0.000903	0.0061	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Estradiol—osteoporosis	0.000902	0.00609	CcSEcCtD
Nitric Oxide—Dyspnoea—Pamidronate—osteoporosis	0.0009	0.00608	CcSEcCtD
Nitric Oxide—Dizziness—Estropipate—osteoporosis	0.000889	0.00601	CcSEcCtD
Nitric Oxide—Dizziness—Alendronate—osteoporosis	0.000875	0.00592	CcSEcCtD
Nitric Oxide—Shock—Conjugated Estrogens—osteoporosis	0.000874	0.0059	CcSEcCtD
Nitric Oxide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000871	0.00589	CcSEcCtD
Nitric Oxide—Hypotension—Zoledronate—osteoporosis	0.000862	0.00582	CcSEcCtD
Nitric Oxide—Dizziness—Raloxifene—osteoporosis	0.000861	0.00582	CcSEcCtD
Nitric Oxide—Dizziness—Ibandronate—osteoporosis	0.000852	0.00576	CcSEcCtD
Nitric Oxide—Headache—Estropipate—osteoporosis	0.000842	0.00569	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—CAP1—osteoporosis	0.000839	0.0182	CbGpPWpGaD
Nitric Oxide—Hypotension—Conjugated Estrogens—osteoporosis	0.00083	0.00561	CcSEcCtD
Nitric Oxide—Headache—Alendronate—osteoporosis	0.000829	0.0056	CcSEcCtD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—CALCA—osteoporosis	0.000829	0.018	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Zoledronate—osteoporosis	0.000822	0.00556	CcSEcCtD
Nitric Oxide—Headache—Raloxifene—osteoporosis	0.000816	0.00551	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—CYP27A1—osteoporosis	0.000814	0.0177	CbGpPWpGaD
Nitric Oxide—Headache—Ibandronate—osteoporosis	0.000807	0.00546	CcSEcCtD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000805	0.0175	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000792	0.00535	CcSEcCtD
Nitric Oxide—Headache—Calcitriol—osteoporosis	0.00079	0.00534	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—MGLL—osteoporosis	0.000748	0.0162	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—MGLL—osteoporosis	0.000748	0.0162	CbGpPWpGaD
Nitric Oxide—Chest pain—Estradiol—osteoporosis	0.000741	0.00501	CcSEcCtD
Nitric Oxide—Dizziness—Ethinyl Estradiol—osteoporosis	0.00072	0.00487	CcSEcCtD
Nitric Oxide—Dizziness—Risedronate—osteoporosis	0.000702	0.00475	CcSEcCtD
Nitric Oxide—Shock—Estradiol—osteoporosis	0.000699	0.00473	CcSEcCtD
Nitric Oxide—Nervous system disorder—Estradiol—osteoporosis	0.000697	0.00471	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—PLEK—osteoporosis	0.000684	0.0148	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—ANXA2—osteoporosis	0.000684	0.0148	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLEK—osteoporosis	0.000684	0.0148	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—ANXA2—osteoporosis	0.000684	0.0148	CbGpPWpGaD
Nitric Oxide—Headache—Ethinyl Estradiol—osteoporosis	0.000682	0.00461	CcSEcCtD
Nitric Oxide—Dizziness—Pamidronate—osteoporosis	0.000668	0.00451	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—MGLL—osteoporosis	0.000667	0.0145	CbGpPWpGaD
Nitric Oxide—Headache—Risedronate—osteoporosis	0.000665	0.0045	CcSEcCtD
Nitric Oxide—Dyspnoea—Estradiol—osteoporosis	0.000634	0.00428	CcSEcCtD
Nitric Oxide—Headache—Pamidronate—osteoporosis	0.000633	0.00427	CcSEcCtD
Nitric Oxide—Dizziness—Zoledronate—osteoporosis	0.00061	0.00412	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—PLEK—osteoporosis	0.00061	0.0132	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—ANXA2—osteoporosis	0.00061	0.0132	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TLN1—osteoporosis	0.00059	0.0128	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TLN1—osteoporosis	0.00059	0.0128	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ADCY5—osteoporosis	0.000589	0.0128	CbGpPWpGaD
Nitric Oxide—Dizziness—Conjugated Estrogens—osteoporosis	0.000587	0.00397	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—VCL—osteoporosis	0.000582	0.0126	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—VCL—osteoporosis	0.000582	0.0126	CbGpPWpGaD
Nitric Oxide—Headache—Zoledronate—osteoporosis	0.000578	0.0039	CcSEcCtD
Nitric Oxide—Headache—Conjugated Estrogens—osteoporosis	0.000556	0.00376	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—TLN1—osteoporosis	0.000526	0.0114	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VCL—osteoporosis	0.000518	0.0112	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000502	0.0109	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000495	0.0107	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAP1A—osteoporosis	0.000486	0.0105	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—RAP1A—osteoporosis	0.000486	0.0105	CbGpPWpGaD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000484	0.0105	CbGpPWpGaD
Nitric Oxide—Dizziness—Estradiol—osteoporosis	0.00047	0.00318	CcSEcCtD
Nitric Oxide—Headache—Estradiol—osteoporosis	0.000445	0.00301	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—FGA—osteoporosis	0.000441	0.00956	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—FGA—osteoporosis	0.000441	0.00956	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAP1A—osteoporosis	0.000433	0.00939	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP19A1—osteoporosis	0.000428	0.00927	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000407	0.00882	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—FGB—osteoporosis	0.000401	0.0087	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—FGB—osteoporosis	0.000401	0.0087	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—FGA—osteoporosis	0.000393	0.00852	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000363	0.00787	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—FGB—osteoporosis	0.000357	0.00775	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000353	0.00764	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000322	0.00698	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.00031	0.00672	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000296	0.00641	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000292	0.00632	CbGpPWpGaD
Nitric Oxide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000287	0.00623	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000264	0.00572	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00026	0.00564	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—POMC—osteoporosis	0.000257	0.00557	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PKM—osteoporosis	0.000242	0.00526	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—FDPS—osteoporosis	0.000242	0.00526	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00024	0.0052	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—ADCY5—osteoporosis	0.000237	0.00515	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPD2—osteoporosis	0.00023	0.00498	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PGLS—osteoporosis	0.00023	0.00498	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000228	0.00495	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000225	0.00488	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP27A1—osteoporosis	0.000216	0.00469	CbGpPWpGaD
Nitric Oxide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000215	0.00466	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000214	0.00464	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000214	0.00464	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000213	0.00462	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ATIC—osteoporosis	0.00021	0.00456	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PNP—osteoporosis	0.00021	0.00456	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000192	0.00416	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000188	0.00408	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000185	0.00401	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IGF1—osteoporosis	0.000182	0.00394	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IGF1—osteoporosis	0.000182	0.00394	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CA2—osteoporosis	0.000179	0.00388	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—OXCT1—osteoporosis	0.000179	0.00388	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MGLL—osteoporosis	0.000174	0.00378	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000165	0.00358	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IGF1—osteoporosis	0.000162	0.00351	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000158	0.00344	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000155	0.00337	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000153	0.00332	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000148	0.00321	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—IDH2—osteoporosis	0.000148	0.00321	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000146	0.00317	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP27A1—osteoporosis	0.000139	0.00302	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ACP5—osteoporosis	0.000135	0.00294	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000128	0.00279	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000128	0.00278	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000127	0.00276	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—TPI1—osteoporosis	0.000126	0.00273	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000126	0.00273	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000126	0.00272	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00012	0.0026	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—P4HB—osteoporosis	0.000118	0.00257	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000118	0.00256	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GAPDH—osteoporosis	0.000116	0.00252	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP19A1—osteoporosis	0.000114	0.00246	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—RAP1A—osteoporosis	0.000113	0.00245	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000112	0.00243	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TGFB1—osteoporosis	0.000109	0.00236	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TGFB1—osteoporosis	0.000109	0.00236	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	9.82e-05	0.00213	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.71e-05	0.00211	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TGFB1—osteoporosis	9.7e-05	0.0021	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	9.69e-05	0.0021	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.33e-05	0.00202	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ENO1—osteoporosis	9.15e-05	0.00198	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PSMA2—osteoporosis	9.02e-05	0.00195	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PSMA5—osteoporosis	9.02e-05	0.00195	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	8.57e-05	0.00186	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.51e-05	0.00185	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.07e-05	0.00175	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.56e-05	0.00164	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP19A1—osteoporosis	7.31e-05	0.00159	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.2e-05	0.00156	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—POMC—osteoporosis	6.82e-05	0.00148	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	6.69e-05	0.00145	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	6.67e-05	0.00145	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	6.66e-05	0.00144	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	6.59e-05	0.00143	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PKM—osteoporosis	6.44e-05	0.0014	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—FDPS—osteoporosis	6.44e-05	0.0014	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.27e-05	0.00136	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	6.21e-05	0.00135	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	6.21e-05	0.00135	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.11e-05	0.00133	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPD2—osteoporosis	6.1e-05	0.00132	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PGLS—osteoporosis	6.1e-05	0.00132	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ADCY5—osteoporosis	5.98e-05	0.0013	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GPX1—osteoporosis	5.96e-05	0.00129	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.84e-05	0.00127	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ATIC—osteoporosis	5.58e-05	0.00121	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PNP—osteoporosis	5.58e-05	0.00121	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—MTHFR—osteoporosis	5.5e-05	0.00119	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.16e-05	0.00112	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.09e-05	0.0011	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.89e-05	0.00106	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CA2—osteoporosis	4.75e-05	0.00103	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—OXCT1—osteoporosis	4.75e-05	0.00103	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MGLL—osteoporosis	4.62e-05	0.001	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—POMC—osteoporosis	4.4e-05	0.000953	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.16e-05	0.000901	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—POMC—osteoporosis	4.02e-05	0.000871	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—IDH2—osteoporosis	3.93e-05	0.000853	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—FDPS—osteoporosis	3.79e-05	0.000822	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PKM—osteoporosis	3.79e-05	0.000822	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP27A1—osteoporosis	3.7e-05	0.000802	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ACP5—osteoporosis	3.6e-05	0.00078	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PGLS—osteoporosis	3.59e-05	0.000779	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPD2—osteoporosis	3.59e-05	0.000779	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TPI1—osteoporosis	3.34e-05	0.000725	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ATIC—osteoporosis	3.29e-05	0.000712	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PNP—osteoporosis	3.29e-05	0.000712	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—P4HB—osteoporosis	3.14e-05	0.000682	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—POMC—osteoporosis	3.1e-05	0.000672	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GAPDH—osteoporosis	3.09e-05	0.000669	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—RAP1A—osteoporosis	3.01e-05	0.000652	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—FDPS—osteoporosis	2.93e-05	0.000634	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PKM—osteoporosis	2.93e-05	0.000634	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—OXCT1—osteoporosis	2.79e-05	0.000606	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CA2—osteoporosis	2.79e-05	0.000606	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PGLS—osteoporosis	2.77e-05	0.000601	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPD2—osteoporosis	2.77e-05	0.000601	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MGLL—osteoporosis	2.72e-05	0.00059	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.57e-05	0.000557	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PNP—osteoporosis	2.54e-05	0.00055	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ATIC—osteoporosis	2.54e-05	0.00055	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ENO1—osteoporosis	2.43e-05	0.000527	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PSMA5—osteoporosis	2.39e-05	0.000519	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PSMA2—osteoporosis	2.39e-05	0.000519	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—IDH2—osteoporosis	2.32e-05	0.000502	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.18e-05	0.000472	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—OXCT1—osteoporosis	2.16e-05	0.000468	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CA2—osteoporosis	2.16e-05	0.000468	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ACP5—osteoporosis	2.12e-05	0.000459	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MGLL—osteoporosis	2.1e-05	0.000456	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.09e-05	0.000453	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TPI1—osteoporosis	1.97e-05	0.000427	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.94e-05	0.000421	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—P4HB—osteoporosis	1.85e-05	0.000401	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GAPDH—osteoporosis	1.82e-05	0.000394	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—IDH2—osteoporosis	1.79e-05	0.000387	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RAP1A—osteoporosis	1.77e-05	0.000384	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.68e-05	0.000364	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ACP5—osteoporosis	1.63e-05	0.000354	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ADCY5—osteoporosis	1.59e-05	0.000344	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GPX1—osteoporosis	1.58e-05	0.000343	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.54e-05	0.000335	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TPI1—osteoporosis	1.52e-05	0.000329	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MTHFR—osteoporosis	1.46e-05	0.000316	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ENO1—osteoporosis	1.43e-05	0.00031	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—P4HB—osteoporosis	1.43e-05	0.00031	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PSMA2—osteoporosis	1.41e-05	0.000306	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PSMA5—osteoporosis	1.41e-05	0.000306	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GAPDH—osteoporosis	1.4e-05	0.000304	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RAP1A—osteoporosis	1.37e-05	0.000296	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—POMC—osteoporosis	1.17e-05	0.000253	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.14e-05	0.000248	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ENO1—osteoporosis	1.1e-05	0.000239	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PSMA2—osteoporosis	1.09e-05	0.000236	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PSMA5—osteoporosis	1.09e-05	0.000236	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ADCY5—osteoporosis	9.34e-06	0.000203	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GPX1—osteoporosis	9.31e-06	0.000202	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP19A1—osteoporosis	8.83e-06	0.000191	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MTHFR—osteoporosis	8.59e-06	0.000186	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ADCY5—osteoporosis	7.21e-06	0.000156	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GPX1—osteoporosis	7.19e-06	0.000156	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—POMC—osteoporosis	6.87e-06	0.000149	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MTHFR—osteoporosis	6.63e-06	0.000144	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—POMC—osteoporosis	5.3e-06	0.000115	CbGpPWpGaD
